Prostate cancer testing after a first negative biopsy
Part of Cancer, Kidney & urinary clinical trials.
This trial looks at whether men with a high suspicion of prostate cancer (PI-RADS 4 or higher) who had a first biopsy that was negative might actually have cancer. It uses a clinical risk model and a special PET scan to decide if a repeat biopsy is needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a prostate MRI that showed a spot suspicious for cancer (PI-RADS 4 or higher)
- Your first prostate biopsy did not find cancer
- A special risk calculator says your chance of cancer is at least 60%
- A PSMA/PET-CT scan after the first biopsy still shows suspicious areas in your prostate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a special PET/MR scan can help guide a second prostate biopsy in men with rising PSA. It may reduce the need for unnecessary biopsies.
This trial is testing a new way to do prostate biopsies by combining MRI findings with a targeted biopsy on the same side as the suspicious area. It is for men who have not had a biopsy before and have a moderately high PSA level.
This trial tests if a special scan called PSMA PET can help diagnose prostate cancer in men whose MRI results are not clear. It may help avoid unnecessary biopsies.
This study tests a new way to guide prostate biopsies using a special scan (PSMA PET/CT) that highlights suspicious areas. If you need a biopsy because of high PSA and abnormal MRI, this approach might help make the biopsy more accurate.
This trial tests whether having repeated MRI scans can help find prostate cancer early in men who have never had a biopsy. It may be a good fit if you have a slightly elevated PSA and a suspicious spot on your first MRI.
This study uses a special type of PET/MRI scan and targeted biopsies to find prostate cancer in men who have a high PSA density but a normal MRI or negative biopsy. It aims to better detect cancer that may be missed by standard tests.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.